Last reviewed · How we verify
NCT06590363
The Effect of Music on Anxiety in the Appointment Period
NA trial testing Listening to zen music in Anxiety in 70 participants. Completed in 14 April 2024.
14 April 2024
Quick facts
| Lead sponsor | Unidade Local de Saúde de Coimbra, EPE |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 70 |
| Start date | 1 January 2024 |
| Primary completion | 14 April 2024 |
| Estimated completion | 14 April 2024 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Listening to zen music
Conditions studied
- Anxiety — all drugs for Anxiety →
Sponsor
Unidade Local de Saúde de Coimbra, EPE — full company profile →
Who can join
18 and older, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized clinical trial is to learn if musical intervention can reduce anxiety on patients and doctors in the appointment period. The main questions it aims to answer are: Can music reduce the psychological symptoms of anxiety at the end of the appointment? Can music reduce heart rate and blood pressure at the end of the appointment? Researchers will compare if the presence of zen music during the appointment influences anxiety levels. Participants in the intervention group will listen to music during the appointment. Those in the control group will not have music in the office during the appointment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06590363
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Unidade Local de Saúde de Coimbra, EPE trials
Trials by the same sponsor.
- NCT06960304 — Effect of a Structured Physical Exercise Program on Arteriovenous Fistula Maturation for Hemodialysis in Chronic Kidney · NA · recruiting
- NCT07113899 — HOPE AND ACCEPTANCE AT THE END OF LIFE - IMPACT OF SPIRITUALITY ON PALLIATIVE CARE PATIENTS · NA · completed
- NCT05389189 — A Tailored Psychological Intervention (MITIG.RA) for Managing Fatigue in Rheumatoid Arthritis · NA · unknown
- NCT06422832 — Remote Monitoring To Identify Worsening Heart Failure The REMOTI-HF Randomized Clinical Trial · NA · not yet recruiting
- NCT06882850 — Immunomodulation During Pregnancy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06590363 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unidade Local de Saúde de Coimbra, EPE
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06590363.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing